International Journal of Medical and Pharmaceutical Research
2025, Volume-6, Issue-1
Original Research Article
Evolution CT Scanners with Advent of PCCT & AI
Published
Feb. 28, 2025
Abstract

CT imaging has evolved significantly, moving from single-slice scanners to multi-slice, dual-energy, and now photon-counting CT (PCCT). Artificial Intelligence (AI) has been integrated into the imaging workflow to improve image reconstruction, diagnostic accuracy, and patient outcomes. This study focuses on the evolution of CT scanners with an emphasis on the advancements brought by PCCT and AI, particularly in a tertiary care setting. Conclusion: Photon-counting CT and AI offer revolutionary advancements in radiology by improving image quality, reducing radiation dose, and enhancing diagnostic precision. Their integration into clinical practice is crucial for personalized patient care and efficient workflow management in tertiary care centers. Introduction CT imaging has undergone remarkable transformation since its inception in the 1970s. The introduction of photon-counting technology and the integration of artificial intelligence are two major milestones that have redefined the diagnostic potential of CT scanners. This evolution is essential for tertiary care centers where high patient volumes and diagnostic accuracy are critical. Aim To study the evolution of CT scanners, focusing on photon-counting technology and AI integration, and their impact on clinical outcomes in a tertiary care setting. Objectives To evaluate the technological advancements from conventional CT to photon-counting CT. To assess the role of AI in improving CT imaging quality and diagnostic accuracy. To analyze the impact of PCCT and AI on radiation dose reduction and patient outcomes. Materials and Methods The study involves a retrospective analysis of the progression of CT technology within a tertiary care center, focusing on the transition from traditional to photon-counting CT and the incorporation of AI-based solutions for imaging and diagnostics. Results Image Quality: PCCT showed a significant improvement in image resolution compared to conventional CT, with sharper images and better material differentiation. Radiation Dose: A reduction in radiation dose was observed with PCCT, with a 20-40% decrease compared to traditional CT techniques. AI Integration: AI-assisted image reconstructions reduced noise and enhanced the diagnostic accuracy, particularly in complex cases. Clinical Outcomes: The combined use of PCCT and AI led to earlier detection of pathologies and more accurate diagnoses, reducing the need for repeat scans. Conclusion: the ongoing advancements in CT technology, marked by the introduction of PCCT and AI, are set to transform medical imaging, offering improved diagnostic accuracy, faster scanning, and reduced radiation exposure, paving the way for more efficient and personalized healthcare solutions.

Recommended Articles
Loading Image...
Volume-6, Issue-1
Citations
1235 Views
73 Downloads
Share this article
License
Copyright (c) International Journal of Medical and Pharmaceutical Research
pdf Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
IJMPR open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Logo
International Journal of Medical and Pharmaceutical Research
About Us
The International Journal of Medical and Pharmaceutical Research (IJMPR) is an EMBASE (Elsevier)–indexed, open-access journal for high-quality medical, pharmaceutical, and clinical research.
Follow Us
© Copyright IJMPR | All Rights Reserved